世界のレーベル遺伝性視神経症治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Leber's Hereditary Optic Neuropathy Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14319
• 出版社/出版日：GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、レーベル遺伝性視神経症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レーベル遺伝性視神経症治療薬の種類別市場規模（エラミプレチド、GS-011、IXC-201、KH-176、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・レーベル遺伝性視神経症治療薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Alkeus Pharmaceuticals, Inc.、Biovista Inc.、GenSight Biologics S.A.、Ixchel Pharma, LLC、Khondrion BV、Spark Therapeutics, Inc.、Stealth BioTherapeutics Inc.
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：エラミプレチド、GS-011、IXC-201、KH-176、その他
・用途別分析2016年-2026年：病院、クリニック、その他
・レーベル遺伝性視神経症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・レーベル遺伝性視神経症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・レーベル遺伝性視神経症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・レーベル遺伝性視神経症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・レーベル遺伝性視神経症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Leber’s Hereditary Optic Neuropathy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Leber’s Hereditary Optic Neuropathy Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Leber’s Hereditary Optic Neuropathy Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Leber’s Hereditary Optic Neuropathy Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Elamipretide
GS-011
IXC-201
KH-176
Others

Market segment by Application can be divided into
Hospital
Clinic
Others

The key market players for global Leber’s Hereditary Optic Neuropathy Drug market are listed below:
Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Leber’s Hereditary Optic Neuropathy Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Leber’s Hereditary Optic Neuropathy Drug, with price, sales, revenue and global market share of Leber’s Hereditary Optic Neuropathy Drug from 2019 to 2021.
Chapter 3, the Leber’s Hereditary Optic Neuropathy Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leber’s Hereditary Optic Neuropathy Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Leber’s Hereditary Optic Neuropathy Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Leber’s Hereditary Optic Neuropathy Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Leber’s Hereditary Optic Neuropathy Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Elamipretide
1.2.3 GS-011
1.2.4 IXC-201
1.2.5 KH-176
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Leber’s Hereditary Optic Neuropathy Drug Market Size & Forecast
1.4.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Value (2016-2026))
1.4.2 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Volume (2016-2026)
1.4.3 Global Leber’s Hereditary Optic Neuropathy Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Leber’s Hereditary Optic Neuropathy Drug Production Capacity Analysis
1.5.1 Global Leber’s Hereditary Optic Neuropathy Drug Total Production Capacity (2016-2026)
1.5.2 Global Leber’s Hereditary Optic Neuropathy Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Leber’s Hereditary Optic Neuropathy Drug Market Drivers
1.6.2 Leber’s Hereditary Optic Neuropathy Drug Market Restraints
1.6.3 Leber’s Hereditary Optic Neuropathy Drug Trends Analysis
2 Manufacturers Profiles
2.1 Alkeus Pharmaceuticals, Inc.
2.1.1 Alkeus Pharmaceuticals, Inc. Details
2.1.2 Alkeus Pharmaceuticals, Inc. Major Business
2.1.3 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.1.4 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Biovista Inc.
2.2.1 Biovista Inc. Details
2.2.2 Biovista Inc. Major Business
2.2.3 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.2.4 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GenSight Biologics S.A.
2.3.1 GenSight Biologics S.A. Details
2.3.2 GenSight Biologics S.A. Major Business
2.3.3 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.3.4 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Ixchel Pharma, LLC
2.4.1 Ixchel Pharma, LLC Details
2.4.2 Ixchel Pharma, LLC Major Business
2.4.3 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.4.4 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Khondrion BV
2.5.1 Khondrion BV Details
2.5.2 Khondrion BV Major Business
2.5.3 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.5.4 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Spark Therapeutics, Inc.
2.6.1 Spark Therapeutics, Inc. Details
2.6.2 Spark Therapeutics, Inc. Major Business
2.6.3 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.6.4 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Stealth BioTherapeutics Inc.
2.7.1 Stealth BioTherapeutics Inc. Details
2.7.2 Stealth BioTherapeutics Inc. Major Business
2.7.3 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Product and Services
2.7.4 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Leber’s Hereditary Optic Neuropathy Drug Sales by Manufacturer
3.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Leber’s Hereditary Optic Neuropathy Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Leber’s Hereditary Optic Neuropathy Drug Manufacturer Market Share
3.4.2 Top 6 Leber’s Hereditary Optic Neuropathy Drug Manufacturer Market Share
3.5 Global Leber’s Hereditary Optic Neuropathy Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Leber’s Hereditary Optic Neuropathy Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size by Region
4.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Region (2016-2026)
4.2 North America Leber’s Hereditary Optic Neuropathy Drug Revenue (2016-2026)
4.3 Europe Leber’s Hereditary Optic Neuropathy Drug Revenue (2016-2026)
4.4 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Revenue (2016-2026)
4.5 South America Leber’s Hereditary Optic Neuropathy Drug Revenue (2016-2026)
4.6 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Type (2016-2026)
5.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Type (2016-2026)
5.3 Global Leber’s Hereditary Optic Neuropathy Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Application (2016-2026)
6.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Application (2016-2026)
6.3 Global Leber’s Hereditary Optic Neuropathy Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2016-2026)
7.2 North America Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2016-2026)
7.3 North America Leber’s Hereditary Optic Neuropathy Drug Market Size by Country
7.3.1 North America Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Leber’s Hereditary Optic Neuropathy Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2016-2026)
8.2 Europe Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2016-2026)
8.3 Europe Leber’s Hereditary Optic Neuropathy Drug Market Size by Country
8.3.1 Europe Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Leber’s Hereditary Optic Neuropathy Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Market Size by Region
9.3.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2016-2026)
10.2 South America Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2016-2026)
10.3 South America Leber’s Hereditary Optic Neuropathy Drug Market Size by Country
10.3.1 South America Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Leber’s Hereditary Optic Neuropathy Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Market Size by Country
11.3.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Leber’s Hereditary Optic Neuropathy Drug Typical Distributors
12.3 Leber’s Hereditary Optic Neuropathy Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Alkeus Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Alkeus Pharmaceuticals, Inc. Major Business
Table 5. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 6. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biovista Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Biovista Inc. Major Business
Table 9. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 10. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GenSight Biologics S.A. Basic Information, Manufacturing Base and Competitors
Table 12. GenSight Biologics S.A. Major Business
Table 13. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 14. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ixchel Pharma, LLC Basic Information, Manufacturing Base and Competitors
Table 16. Ixchel Pharma, LLC Major Business
Table 17. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 18. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Khondrion BV Basic Information, Manufacturing Base and Competitors
Table 20. Khondrion BV Major Business
Table 21. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 22. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Spark Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Spark Therapeutics, Inc. Major Business
Table 25. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 26. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Stealth BioTherapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Stealth BioTherapeutics Inc. Major Business
Table 29. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 30. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 32. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Leber's Hereditary Optic Neuropathy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Leber's Hereditary Optic Neuropathy Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 35. Head Office and Leber's Hereditary Optic Neuropathy Drug Production Site of Key Manufacturer
Table 36. Leber's Hereditary Optic Neuropathy Drug New Entrant and Capacity Expansion Plans
Table 37. Leber's Hereditary Optic Neuropathy Drug Mergers & Acquisitions in the Past Five Years
Table 38. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2016-2021e) & (K Pcs)
Table 39. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021-2026) & (K Pcs)
Table 40. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 43. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 44. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 47. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2026) & (USD/Pcs)
Table 48. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 49. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 50. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 53. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2026) & (USD/Pcs)
Table 54. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2016-2021e) & (K Pcs)
Table 55. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Pcs)
Table 56. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 59. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 60. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 61. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 62. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2016-2021e) & (K Pcs)
Table 63. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Pcs)
Table 64. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 67. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 68. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 69. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021-2026) & (K Pcs)
Table 72. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 77. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 78. South America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2016-2021e) & (K Pcs)
Table 79. South America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Pcs)
Table 80. South America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 83. South America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 84. South America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 85. South America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Pcs)
Table 88. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Leber's Hereditary Optic Neuropathy Drug Typical Distributors
Table 97. Leber's Hereditary Optic Neuropathy Drug Typical Customers
List of Figures
Figure 1. Leber's Hereditary Optic Neuropathy Drug Picture
Figure 2. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2020
Figure 3. Elamipretide
Figure 4. GS-011
Figure 5. IXC-201
Figure 6. KH-176
Figure 7. Others
Figure 8. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Leber's Hereditary Optic Neuropathy Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Leber's Hereditary Optic Neuropathy Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Sales (2016-2026) & (K Pcs)
Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Leber's Hereditary Optic Neuropathy Drug Market Drivers
Figure 19. Leber's Hereditary Optic Neuropathy Drug Market Restraints
Figure 20. Leber's Hereditary Optic Neuropathy Drug Market Trends
Figure 21. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Leber's Hereditary Optic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Leber's Hereditary Optic Neuropathy Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Leber's Hereditary Optic Neuropathy Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Leber's Hereditary Optic Neuropathy Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Leber's Hereditary Optic Neuropathy Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Leber's Hereditary Optic Neuropathy Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

以下、関連資料のご紹介

視神経症薬市場：世界及び中国市場分析・予測（～2024年）

Optic Neuropathy Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT4754 2019年10月8日 142Pages
「視神経症薬市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における視神経症薬市場について調査・分析したレポートで、視神経症薬の世界市場動向、市場規模、主要企業情報などが含まれています。視神経症薬のタイプ別には、BA-240、IWP-953、LM-22A4、その他に分けて分析し、地...

世界の糖尿病性ニューロパチー治療薬市場 2021：企業別、地域別、種類・用途別

Global Diabetic Neuropathy Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12216 2021年7月 102Pages
当調査資料では、糖尿病性ニューロパチー治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病性ニューロパチー治療薬の種類別市場規模（カルシウムチャネルアルファ2デルタリガンド、SNRI・TCA、その他）、用途別市場規模（病院、ドラッグストア、その...

世界の光ファイバーセラミック市場 2021：企業別、地域別、種類・用途別

Global Fiber Optic Ceramics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A02232 2021年7月 76Pages
当調査資料では、光ファイバーセラミックのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。光ファイバーセラミックの種類別市場規模（SC光ファイバーセラミック、LC光ファイバーセラミック）、用途別市場規模（光ファイバコネクタ、光ファイバトランシーバ、光モジュ...

世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別

Global Hypothyroidism Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12364 2021年7月 74Pages
当調査資料では、甲状腺機能低下症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。甲状腺機能低下症治療薬の種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、クリニック、その他）、...

世界のゴセレリン薬市場 2021：企業別、地域別、種類・用途別

Global Goserelin Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A14591 2021年7月 76Pages
当調査資料では、ゴセレリン薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ゴセレリン薬の種類別市場規模（3.6 mg、10.8 mg）、用途別市場規模（前立腺がん、乳がん、子宮内膜症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国...

世界の航空機用光ファイバーコネクタ市場 2021：企業別、地域別、種類・用途別

Global Aerospace Fiber Optic Connectors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A08452 2021年7月 105Pages
当調査資料では、航空機用光ファイバーコネクタのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。航空機用光ファイバーコネクタの種類別市場規模（シングルモードコネクタ、マルチモードコネクタ）、用途別市場規模（民間航空宇宙、軍事航空宇宙、その他）、地域別市場規...

世界の光ファイバー受信機市場 2021：企業別、地域別、種類・用途別

Global Fiber Optic Receiver Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A06204 2021年7月 95Pages
当調査資料では、光ファイバー受信機のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。光ファイバー受信機の種類別市場規模（FC、SC、ST、LC、D4、DIN、MU、MT）、用途別市場規模（学校、オフィス、エンターテインメント、その他）、地域別市場規模（北...

世界のオベチコール酸薬品市場 2021：企業別、地域別、種類・用途別

Global Obeticholic Acid Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A14845 2021年7月 104Pages
当調査資料では、オベチコール酸薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オベチコール酸薬品の種類別市場規模（5mg、10mg）、用途別市場規模（原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の光ファイバーケーブルスプリットファイバーボックス市場 2021：企業別、地域別、種類・用途別

Global Fiber Optic Cable Split Fiber Box Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A06201 2021年7月 104Pages
当調査資料では、光ファイバーケーブルスプリットファイバーボックスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。光ファイバーケーブルスプリットファイバーボックスの種類別市場規模（1：4、1：8、1：16、1：32）、用途別市場規模（家庭用、商業、産業）...

世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別

Global Drug of Abuse Testing Services Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12233 2021年7月 80Pages
当調査資料では、薬物乱用検査サービスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。薬物乱用検査サービスの種類別市場規模（アルコール、大麻、コカイン、オピオイド、アンフェタミン、LSD、その他）、用途別市場規模（病院、研究所、その他）、地域別市場規模（...

視神経症薬市場：世界及び中国市場分析・予測（～2024年） Optic Neuropathy Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Optic Neuropathy Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Optic Neuropathy Drug manu…
世界の糖尿病性ニューロパチー治療薬市場 2021：企業別、地域別、種類・用途別 The Diabetic Neuropathy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
心臓自律神経障害用治療市場：世界及び中国市場分析・予測（～2024年） Cardiac Autonomic Neuropathy Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cardiac Autonomic Neuropathy Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status…
世界の光ファイバーセラミック市場 2021：企業別、地域別、種類・用途別 The Fiber Optic Ceramics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
世界の航空機用光ファイバーコネクタ市場 2021：企業別、地域別、種類・用途別 The Aerospace Fiber Optic Connectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…